EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species

Mei-Chen Tan, Ying-Chi Huang, Pei-Jing Chen, Wei-Cheng Huang, Shu-Yuan Hsu, Hui-Ying Wang, Ci-Hong Liou, Jun-Ren Sun, Tsai-Ling Yang Lauderdale, Shu-Chen Kuo iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkad322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Mei-Chen Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan. Hauptthemen laut MEDLINE: Flavobacteriaceae Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health Research Institutes, Ministry of Science and Technology, MOST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flavobacteriaceae InfectionsHumansPiperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsPiperacillinPenicillanic AcidMicrobial Sensitivity TestsDrug Therapy, Combinationbeta-Lactamase Inhibitors

Substanzen

Piperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsPiperacillinPenicillanic Acidbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan.
  • Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan.
  • Department of Pathology, Division of Clinical Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

ORCID-Profile: Shu-Chen Kuo

Förderung

  • National Health Research Institutes
  • Ministry of Science and Technology
  • MOST

Zitieren

APA

Tan, M. C., Huang, Y. C., Chen, P. J., Huang, W. C., Hsu, S. Y., Wang, H. Y., Liou, C. H., Sun, J. R., Lauderdale, T. Y., & Kuo, S. C. (2024). In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad322

Vancouver

Tan MC, Huang YC, Chen PJ, Huang WC, Hsu SY, Wang HY, et al. In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkad322

BibTeX
@article{Tan2024,
  author = {Tan, Mei-Chen and Huang, Ying-Chi and Chen, Pei-Jing and Huang, Wei-Cheng and Hsu, Shu-Yuan and Wang, Hui-Ying and Liou, Ci-Hong and Sun, Jun-Ren and Lauderdale, Tsai-Ling Yang and Kuo, Shu-Chen},
  title = {In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkad322}
}
Kostenlos starten →